Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96


Molecular characterization of pro-metastatic functions of β4-integrin in colorectal cancer.

Zhang W, Zhang B, Vu T, Yuan G, Zhang B, Chen X, Manne U, Datta PK.

Oncotarget. 2017 Sep 27;8(54):92333-92345. doi: 10.18632/oncotarget.21290. eCollection 2017 Nov 3.


Prostate cancer health disparities: An immuno-biological perspective.

Kumar S, Singh R, Malik S, Manne U, Mishra M.

Cancer Lett. 2018 Feb 1;414:153-165. doi: 10.1016/j.canlet.2017.11.011. Epub 2017 Nov 15.


Bromoethylindole (BEI-9) redirects NF-κB signaling induced by camptothecin and TNFα to promote cell death in colon cancer cells.

Chowdhury R, Gales D, Valenzuela P, Miller S, Yehualaeshet T, Manne U, Francia G, Samuel T.

Apoptosis. 2017 Dec;22(12):1553-1563. doi: 10.1007/s10495-017-1427-6.


Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.

Katkoori VR, Manne U, Chaturvedi LS, Basson MD, Haan P, Coffey D, Bumpers HL.

Oncotarget. 2017 Aug 29;8(44):76574-76586. doi: 10.18632/oncotarget.20580. eCollection 2017 Sep 29.


Prolonged exposure of resveratrol induces reactive superoxide species-independent apoptosis in murine prostate cells.

Kumar S, Stokes J 3rd, Singh UP, Scissum-Gunn K, Singh R, Manne U, Mishra MK.

Tumour Biol. 2017 Oct;39(10):1010428317715039. doi: 10.1177/1010428317715039.


miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.

Chakravarthi BVSK, Chandrashekar DS, Agarwal S, Balasubramanya SAH, Pathi SS, Goswami MT, Jing X, Wang R, Mehra R, Asangani IA, Chinnaiyan AM, Manne U, Sonpavde G, Netto GJ, Gordetsky J, Varambally S.

Mol Cancer Res. 2017 Oct 12. doi: 10.1158/1541-7786.MCR-17-0230. [Epub ahead of print]


Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.

Manne U, Jadhav T, Putcha BK, Samuel T, Soni S, Shanmugam C, Suswam EA.

Curr Colorectal Cancer Rep. 2016 Dec;12(6):332-344. doi: 10.1007/s11888-016-0338-1. Epub 2016 Sep 20.


Label-free detection of DNA hybridization with a compact LSPR-based fiber-optic sensor.

Kaye S, Zeng Z, Sanders M, Chittur K, Koelle PM, Lindquist R, Manne U, Lin Y, Wei J.

Analyst. 2017 Jun 7;142(11):1974-1981. doi: 10.1039/c7an00249a. Epub 2017 May 15.


Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.

Jia X, Shanmugam C, Paluri RK, Jhala NC, Behring MP, Katkoori VR, Sugandha SP, Bae S, Samuel T, Manne U.

Oncotarget. 2017 Mar 21;8(12):20198-20212. doi: 10.18632/oncotarget.15560.


Single molecule mtDNA fiber FISH for analyzing numtogenesis.

Koo DH, Singh B, Jiang J, Friebe B, Gill BS, Chastain PD, Manne U, Tiwari HK, Singh KK.

Anal Biochem. 2017 Mar 18. pii: S0003-2697(17)30131-8. doi: 10.1016/j.ab.2017.03.015. [Epub ahead of print]


Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas.

Council LN, Shanmugam C, Suswam EA, Katkoori VR, Heslin MJ, Hanna A, Jhala NC, Varambally S, Manne U.

J Dig Dis Hepatol. 2016;2016(5). pii: JDDH-121. Epub 2016 Dec 23.


Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells.

Kumar S, Eroglu E, Stokes JA 3rd, Scissum-Gunn K, Saldanha SN, Singh UP, Manne U, Ponnazhagan S, Mishra MK.

Oncotarget. 2017 Mar 28;8(13):20895-20908. doi: 10.18632/oncotarget.14947.


A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.

Govindarajan R, Posey J, Chao CY, Lu R, Jadhav T, Javed AY, Javed A, Mahmoud FA, Osarogiagbon RU, Manne U.

BMC Cancer. 2016 Jun 18;16:368. doi: 10.1186/s12885-016-2365-3.


Targeting Hsp70: A possible therapy for cancer.

Kumar S, Stokes J 3rd, Singh UP, Scissum Gunn K, Acharya A, Manne U, Mishra M.

Cancer Lett. 2016 Apr 28;374(1):156-166. doi: 10.1016/j.canlet.2016.01.056. Epub 2016 Feb 17. Review.


Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.

Krishn SR, Kaur S, Smith LM, Johansson SL, Jain M, Patel A, Gautam SK, Hollingsworth MA, Mandel U, Clausen H, Lo WC, Fan WT, Manne U, Batra SK.

Cancer Lett. 2016 May 1;374(2):304-14. doi: 10.1016/j.canlet.2016.02.016. Epub 2016 Feb 16.


Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo.

Narayanan NK, Kunimasa K, Yamori Y, Mori M, Mori H, Nakamura K, Miller G, Manne U, Tiwari AK, Narayanan B.

Cancer Med. 2015 Nov;4(11):1767-80. doi: 10.1002/cam4.520. Epub 2015 Sep 26.


Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.

Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL.

Oncotarget. 2015 Sep 29;6(29):27763-77. doi: 10.18632/oncotarget.4615.


Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.

Putcha BD, Jia X, Katkoori VR, Salih C, Shanmugam C, Jadhav T, Bovell LC, Behring MP, Callens T, Messiaen L, Bae S, Grizzle WE, Singh KP, Manne U.

PLoS One. 2015 Jun 12;10(6):e0129216. doi: 10.1371/journal.pone.0129216. eCollection 2015.


3-(2-Bromoethyl)-indole inhibits the growth of cancer cells and NF-κB activation.

Fadlalla K, Elgendy R, Gilbreath E, Pondugula SR, Yehualaeshet T, Mansour M, Serbessa T, Manne U, Samuel T.

Oncol Rep. 2015 Jul;34(1):495-503. doi: 10.3892/or.2015.3970. Epub 2015 May 11.


Nanomagnetic levitation three-dimensional cultures of breast and colorectal cancers.

Bumpers HL, Janagama DG, Manne U, Basson MD, Katkoori V.

J Surg Res. 2015 Apr;194(2):319-26. doi: 10.1016/j.jss.2014.12.036. Epub 2014 Dec 23.


IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.

Karthikeyan C, Lee C, Moore J, Mittal R, Suswam EA, Abbott KL, Pondugula SR, Manne U, Narayanan NK, Trivedi P, Tiwari AK.

Bioorg Med Chem. 2015 Feb 1;23(3):602-11. doi: 10.1016/j.bmc.2014.11.043. Epub 2014 Dec 8.


Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model.

Tabatabai MA, Kengwoung-Keumo JJ, Eby WM, Bae S, Guemmegne JT, Manne U, Fouad M, Partridge EE, Singh KP.

PLoS One. 2014 Sep 16;9(9):e107242. doi: 10.1371/journal.pone.0107242. eCollection 2014.


Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.

Samuel T, Fadlalla K, Gales DN, Putcha BD, Manne U.

BMC Cancer. 2014 Aug 18;14:599. doi: 10.1186/1471-2407-14-599.


A New Robust Method for Nonlinear Regression.

Tabatabai MA, Kengwoung-Keumo JJ, Eby WM, Bae S, Manne U, Fouad M, Singh KP.

J Biom Biostat. 2014;5(5):211.


Robust Logistic and Probit Methods for Binary and Multinomial Regression.

Tabatabai MA, Li H, Eby WM, Kengwoung-Keumo JJ, Manne U, Bae S, Fouad M, Singh KP.

J Biom Biostat. 2014;5(4). pii: 202.


The Chemokine CXCL8 in Carcinogenesis and Drug Response.

Gales D, Clark C, Manne U, Samuel T.

ISRN Oncol. 2013 Oct 9;2013:859154. doi: 10.1155/2013/859154. Review.


Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer.

Bumpers H, Huang MB, Katkoori V, Manne U, Bond V.

J Cancer Ther. 2013 Jun;4(4):898-906.


The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer.

Bovell LC, Shanmugam C, Putcha BD, Katkoori VR, Zhang B, Bae S, Singh KP, Grizzle WE, Manne U.

Clin Cancer Res. 2013 Jul 15;19(14):3955-65. doi: 10.1158/1078-0432.CCR-12-3302. Epub 2013 May 29.


Clinical implications of microRNAs in cancer.

Bovell LC, Putcha BD, Samuel T, Manne U.

Biotech Histochem. 2013 Oct;88(7):388-96. doi: 10.3109/10520295.2013.788735. Epub 2013 May 7. Review.


Socioeconomic status, p53 abnormalities, and colorectal cancer.

Vogtmann E, Shanmugam C, Katkoori VR, Waterbor J, Manne U.

J Gastrointest Oncol. 2013 Mar;4(1):40-4. doi: 10.3978/j.issn.2078-6891.2012.054.


Post-transcriptional processing of genetic information and its relation to cancer.

McNally L, Manne U, Grizzle WE.

Biotech Histochem. 2013 Oct;88(7):365-72. doi: 10.3109/10520295.2012.730152. Epub 2013 Jan 4.


Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.

Katkoori VR, Manne K, Vital-Reyes VS, Rodríguez-Burford C, Shanmugam C, Sthanam M, Manne U, Chatla C, Abdulkadir SA, Grizzle WE.

Biotech Histochem. 2013 Jan;88(1):38-46. doi: 10.3109/10520295.2012.724713. Epub 2012 Nov 21.


Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients.

Bowman E, Oprea G, Okoli J, Gundry K, Rizzo M, Gabram-Mendola S, Manne U, Smith G, Pambuccian S, Bumpers HL.

Breast J. 2012 May-Jun;18(3):242-7. doi: 10.1111/j.1524-4741.2012.01230.x.


Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583.

Tuupanen S, Yan J, Turunen M, Gylfe AE, Kaasinen E, Li L, Eng C, Culver DA, Kalady MF, Pennison MJ, Pasche B, Manne U, de la Chapelle A, Hampel H, Henderson BE, Marchand LL, Hautaniemi S, Askhtorab H, Smoot D, Sandler RS, Keku T, Kupfer SS, Ellis NA, Haiman CA, Taipale J, Aaltonen LA.

Cancer Genet. 2012 Jan-Feb;205(1-2):25-33. doi: 10.1016/j.cancergen.2012.01.005.


Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas.

Katkoori VR, Shanmugam C, Jia X, Vitta SP, Sthanam M, Callens T, Messiaen L, Chen D, Zhang B, Bumpers HL, Samuel T, Manne U.

PLoS One. 2012;7(1):e30020. doi: 10.1371/journal.pone.0030020. Epub 2012 Jan 19.


Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.

Samuel T, Fadlalla K, Mosley L, Katkoori V, Turner T, Manne U.

Anticancer Res. 2012 Jan;32(1):61-71.


miRNAs are stable in colorectal cancer archival tissue blocks.

Bovell L, Shanmugam C, Katkoori VR, Zhang B, Vogtmann E, Grizzle WE, Manne U.

Front Biosci (Elite Ed). 2012 Jan 1;4:1937-40.


Development and progression of colorectal neoplasia.

Manne U, Shanmugam C, Katkoori VR, Bumpers HL, Grizzle WE.

Cancer Biomark. 2010;9(1-6):235-65. doi: 10.3233/CBM-2011-0160. Review.


The biology of incipient, pre-invasive or intraepithelial neoplasia.

Grizzle WE, Srivastava S, Manne U.

Cancer Biomark. 2010;9(1-6):21-39. doi: 10.3233/CBM-2011-0172.


Translational pathology of neoplasia.

Grizzle WE, Srivastava S, Manne U.

Cancer Biomark. 2010;9(1-6):7-20. doi: 10.3233/CBM-2011-0159.


Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue.

Kennedy RD, Bylesjo M, Kerr P, Davison T, Black JM, Kay EW, Holt RJ, Proutski V, Ahdesmaki M, Farztdinov V, Goffard N, Hey P, McDyer F, Mulligan K, Mussen J, O'Brien E, Oliver G, Walker SM, Mulligan JM, Wilson C, Winter A, O'Donoghue D, Mulcahy H, O'Sullivan J, Sheahan K, Hyland J, Dhir R, Bathe OF, Winqvist O, Manne U, Shanmugam C, Ramaswamy S, Leon EJ, Smith WI Jr, McDermott U, Wilson RH, Longley D, Marshall J, Cummins R, Sargent DJ, Johnston PG, Harkin DP.

J Clin Oncol. 2011 Dec 10;29(35):4620-6. doi: 10.1200/JCO.2011.35.4498. Epub 2011 Nov 7.


Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer.

Shanmugam C, Hines RB, Jhala NC, Katkoori VR, Zhang B, Posey JA Jr, Bumpers HL, Grizzle WE, Eltoum IE, Siegal GP, Manne U.

J Hematol Oncol. 2011 May 28;4:25. doi: 10.1186/1756-8722-4-25.


Development of combination tapered fiber-optic biosensor dip probe for quantitative estimation of interleukin-6 in serum samples.

Wang CW, Manne U, Reddy VB, Oelschlager DK, Katkoori VR, Grizzle WE, Kapoor R.

J Biomed Opt. 2010 Nov-Dec;15(6):067005. doi: 10.1117/1.3523368. Erratum in: J Biomed Opt. 2011 Jan-Feb;16(1):019801.


Bax expression is a candidate prognostic and predictive marker of colorectal cancer.

Katkoori VR, Suarez-Cuervo C, Shanmugam C, Jhala NC, Callens T, Messiaen L, Posey J 3rd, Bumpers HL, Meleth S, Grizzle WE, Manne U.

J Gastrointest Oncol. 2010 Dec;1(2):76-89. doi: 10.3978/j.issn.2078-6891.2010.019.


miRNAs as biomarkers for management of patients with colorectal cancer.

Manne U, Shanmugam C, Bovell L, Katkoori VR, Bumpers HL.

Biomark Med. 2010 Oct;4(5):761-70. doi: 10.2217/bmm.10.87. Review.


Standards for immunohistochemical imaging: a protein reference device for biomarker quantitation.

Atha DH, Manne U, Grizzle WE, Wagner PD, Srivastava S, Reipa V.

J Histochem Cytochem. 2010 Nov;58(11):1005-14. doi: 10.1369/jhc.2010.956342. Epub 2010 Aug 30.


Prognostic value of mucin 4 expression in colorectal adenocarcinomas.

Shanmugam C, Jhala NC, Katkoori VR, Wan W, Meleth S, Grizzle WE, Manne U.

Cancer. 2010 Aug 1;116(15):3577-86. doi: 10.1002/cncr.25095.


Comparison of the predictive qualities of three prognostic models of colorectal cancer.

Anderson B, Hardin JM, Alexander DD, Grizzle WE, Meleth S, Manne U.

Front Biosci (Elite Ed). 2010 Jun 1;2:849-56.


HIV Nef-M1 Effects on Colorectal Cancer Growth in Tumor-induced Spleens and Hepatic Metastasis.

Harrington W, Bond V, Huang MB, Powell M, Lillard J, Manne U, Bumpers H.

Mol Cell Pharmacol. 2009 Aug 5;1(2):85-91.


Quantitative Estimation of IL-6 in Serum/Plasma Samples Using a Rapid and Cost-Effective Fiber-Optic dip-probe.

Wang CW, Manne U, Reddy VB, Kapoor R.

Proc SPIE Int Soc Opt Eng. 2010 Jan 23;7559(75590G). pii: 75590G_1.

Supplemental Content

Support Center